I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The safety concerns regarding immune checkpoint inhibitors ..:
Shike Lou
;
Zhujun Cao
;
Wanqing Chi
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1164309/full. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1164309
RT Journal T1 <Title>The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:be93bbaabd00471ab2a33a0cf5ff268d&Exemplar=1&LAN=DE A1 Shike Lou A1 Zhujun Cao A1 Wanqing Chi A1 Xiaoyin Wang A1 Mingyang Feng A1 Lanyi Lin A1 Yezhou Ding A1 Kehui Liu A1 Lihong Qu A1 Gangde Zhao A1 Shisan Bao A1 Hui Wang PB Frontiers Media S.A. YR 2023 K1 primary liver cancer K1 immune checkpoint inhibitor K1 immunotherapy K1 combined therapy K1 immune-related adverse events K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2023.1164309/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1164309 DO https://doi.org/10.3389/fphar.2023.1164309 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
